Blockade of spatial learning by the M1 muscarinic antagonist pirenzepine
- PMID: 3124181
- DOI: 10.1007/BF00207237
Blockade of spatial learning by the M1 muscarinic antagonist pirenzepine
Abstract
Two experiments were conducted to determine the effects of the M1 muscarinic receptor antagonist pirenzepine on place navigation in a water maze. In the first experiment rats were required to learn the location of a hidden platform following intracerebroventricular injections of equimolar doses of pirenzepine or scopolamine methylbromide. Both drugs dose-dependently impaired spatial learning according to both escape latency data and transfer test analysis. Pirenzepine was approximately 3 times less potent than scopolamine, a potency ratio which suggests M1 receptor mediation of the impairment. In the second experiment pirenzepine (1 approximately 92.3 micrograms/rat ICV) was injected prior to training on a simultaneous place discrimination task in the water maze. Impairments of choice accuracy were found with a dose of 20 micrograms/rat in the absence of any marked increases in either errors of omission or choice latency. These data suggest that M1 receptor blockade impairs processes which are involved in spatial learning.
Similar articles
-
The effect of pirenzepine on spatial learning in the Morris Water Maze.Pharmacol Biochem Behav. 1988 Jun;30(2):519-23. doi: 10.1016/0091-3057(88)90490-x. Pharmacol Biochem Behav. 1988. PMID: 3174783
-
Effects of intracerebroventricular pirenzepine on muscarinic discriminations in rats.Eur J Pharmacol. 1987 Jul 2;139(1):111-6. doi: 10.1016/0014-2999(87)90504-8. Eur J Pharmacol. 1987. PMID: 3653237
-
Infralimbic muscarinic M1 receptors modulate anxiety-like behaviour and spontaneous working memory in mice.Psychopharmacology (Berl). 2001 Apr;155(1):58-68. doi: 10.1007/s002130000671. Psychopharmacology (Berl). 2001. PMID: 11374337
-
Muscarinic receptor subtypes and sexual behavior in female rats.Pharmacol Biochem Behav. 1991 Jan;38(1):115-24. doi: 10.1016/0091-3057(91)90598-v. Pharmacol Biochem Behav. 1991. PMID: 1708147
-
Dissociating performance and learning deficits on spatial navigation tasks in rats subjected to cholinergic muscarinic blockade.Brain Res Bull. 1989 Oct-Nov;23(4-5):347-58. doi: 10.1016/0361-9230(89)90221-9. Brain Res Bull. 1989. PMID: 2686805 Review.
Cited by
-
Network activity in neurons of the motor and prefrontal areas of the cortex in trained cats in conditions of systemic administration of m-cholinoreceptor blockers.Neurosci Behav Physiol. 2002 Nov-Dec;32(6):631-42. doi: 10.1023/a:1020465829338. Neurosci Behav Physiol. 2002. PMID: 12469892
-
Cholinergic targets for cognitive enhancement in schizophrenia: focus on cholinesterase inhibitors and muscarinic agonists.Psychopharmacology (Berl). 2004 Jun;174(1):45-53. doi: 10.1007/s00213-004-1794-x. Epub 2004 Feb 19. Psychopharmacology (Berl). 2004. PMID: 15205878 Review.
-
The utility of muscarinic agonists in the treatment of Alzheimer's disease.J Mol Neurosci. 2002 Aug-Oct;19(1-2):187-93. doi: 10.1007/s12031-002-0031-5. J Mol Neurosci. 2002. PMID: 12212779
-
The M1 muscarinic agonist CI-1017 facilitates trace eyeblink conditioning in aging rabbits and increases the excitability of CA1 pyramidal neurons.J Neurosci. 2000 Jan 15;20(2):783-90. doi: 10.1523/JNEUROSCI.20-02-00783.2000. J Neurosci. 2000. PMID: 10632607 Free PMC article.
-
Characterization of a CNS penetrant, selective M1 muscarinic receptor agonist, 77-LH-28-1.Br J Pharmacol. 2008 Jul;154(5):1104-15. doi: 10.1038/bjp.2008.152. Epub 2008 May 5. Br J Pharmacol. 2008. PMID: 18454168 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources